01 3Blake Cassels & Graydon LLP
01 32418961
01 1USTEKINUMAB
02 2Ustekinumab
01 1SOLUTION
02 1Solution (Vial) / Solution (pre-filled syringe)
03 1Solution (Vial) / Solution (pre-filled syringe)
01 32021-08-07
Patent Expiration Date : 2021-08-07
Date Granted : 2009-11-03
Brand Name : STELARA
Patent Number : 2418961
Filing Date : 2001-08-07
Strength per Unit : 45 mg / 0.5 mL
Dosage Form : Solution (Vial) / Solution (pre-filled syringe)
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2021-08-07
Date Granted : 2009-11-03
Patent Expiration Date : 2021-08-07
Date Granted : 2009-11-03
Brand Name : STELARA
Patent Number : 2418961
Filing Date : 2001-08-07
Strength per Unit : 90 mg / 1.0 mL
Dosage Form : Solution (Vial) / Solution (pre-filled syringe)
Human Or VET : Human
Route of Administration : Subcutaneous Injection
Patent Expiration Date : 2021-08-07
Date Granted : 2009-11-03
Patent Expiration Date : 2021-08-07
Date Granted : 2009-11-03
Brand Name : STELARA I.V.
Patent Number : 2418961
Filing Date : 2001-08-07
Strength per Unit : 5 mg / mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2021-08-07
Date Granted : 2009-11-03
LOOKING FOR A SUPPLIER?
